A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer
Clinical trial NCT05275777 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05275777
- Sponsor
- National University Hospital, Singapore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2027-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.